UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2023
Commission File Number: 001-34563
CONCORD MEDICAL SERVICES HOLDINGS
LIMITED
Room 26A1-26A5, East Tower, Hanwei Building
No. 7 Guanghua Road, Chaoyang District
Beijing 100013
People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
CONCORD MEDICAL SERVICES HOLDINGS LIMITED |
| |
|
|
| |
By: |
/s/ Jianyu Yang |
| |
Name: |
Jianyu Yang |
| |
Title: |
Chairman and Chief Executive Officer |
Date: November 20, 2023
Exhibit Index
Exhibit 99.1
Concord Medical Schedules 2023 Annual Meeting
of Shareholders
BEIJING, November 20, 2023 /PRNewswire/
-- Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider
specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating
an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2023 annual general
meeting of shareholders (the “Meeting”) on December 26, 2023, at 10:00 a.m. (Beijing Time). The meeting will be
held at Room 26A1-26A5, East Tower, Hanwei Building, No. 7 Guanghua Road, Chaoyang District, Beijing, China. The shareholder record
date is November 27, 2023. A copy of the notice of Meeting is available on the Company’s investor relations website at https://ir.ccm.cn.
No proposal will be submitted for shareholder
approval at the Meeting. Instead, the Meeting will be convened for shareholders who are entitled to vote to discuss Company affairs with
management. Concord Medical’s annual report on Form 20-F filed with the U.S. Securities and Exchange Commission, containing
the Company’s audited financial statements for the financial year ended December 31, 2022, is available in the Investor Relations
section of the Company’s website at http://ir.ccm.cn. The Form 20-F is also available on the SEC’s website
at http://www.sec.gov.
About Concord Medical
Concord Medical Services Holdings Limited is a
healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention.
The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals
and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving
to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered
hospitals across China. For more information, please see http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements.
These forward-looking statements can be identified by words or phrases such as “will,” “expects,” “anticipates,”
“future,” “intends,” “plans,” “believes,” “estimates” and similar expressions.
Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company’s control and based upon
premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results
to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any
forward-looking statement, except as required under applicable law.
For more information, please contact:
Concord Medical Services Holdings Limited
Investor Relations
+86 10 5903 6688
ir@ccm.cn
Exhibit 99.2
Concord
Medical Services Holdings Limited
(the "Company")
| NOTICE OF Annual GENERAL MEETING |
NOTICE is hereby given that an annual general
meeting of the Company (the “Meeting”) will be held on December 26, 2023 at Room 26A1-26A5, East Tower, Hanwei
Building, No. 7 Guanghua Road, Chaoyang District, Beijing, P.R. China at 10:00 A.M. (Beijing time). No proposal will be submitted
for shareholder approval at the Meeting. Instead, the Meeting will be convened for shareholders who are entitled to vote to discuss Company
affairs with management.
The board of directors of the Company has fixed
the close of business on November 27, 2023 as the record date (the “Record Date”) for determining the shareholders
entitled to receive notice of the Meeting or any adjournment thereof.
Holders of record of the Company’s ordinary
shares at the close of business on the Record Date are entitled to attend the Meeting and any adjournment or postponement thereof.
A shareholder entitled to attend the Meeting is
entitled to appoint a proxy to attend on his/her behalf. A proxy need not be a shareholder of the Company. A form of proxy is attached.
To be valid, the form of proxy must be duly completed,
signed and delivered (in the case of a corporation, the form of proxy should be given under such shareholder’s common seal or under
the hand of an officer, attorney or other person duly authorised in writing to sign the same) to Room 26A1-26A5, East Tower, Hanwei Building,
No. 7 Guanghua Road, Chaoyang District, Beijing, P.R. China for the attention of director Yang Jianyu or emailed to botao.shi@ccm.cn
no later than the time for holding the Meeting or the adjourned meeting at which the proxy is to be used.
Shareholders and holders of American depositary
shares of the Company may obtain a copy of the Company’s annual report on Form 20-F, containing the Company’s audited
financial statements for the financial year ended December 31, 2022, from the Investor Relations section of the Company’s website
at http://ir.ccm.cn or the website of the Securities and Exchange Commission at http://www.sec.gov.
By the Order of the Board of Directors,
CONCORD MEDICAL SERVICES HOLDINGS LIMITED |
|
| |
|
| /s/ Jianyu Yang |
|
| Chairman |
|
| Date: November 20, 2023 |
|
Exhibit 99.3
Concord Medical Services Holdings Limited
(the “Company”)
PROXY
I/We* (name) of
(address),
the holder of
(number) Class A
ordinary shares and (number) Class B
ordinary shares in the Company, hereby appoint (name)
of (address) and/or* failing him/her*,
(name) of
(address),
or failing him/her/them*, the Chairman of the meeting as my/our proxy/proxies* to attend on my/our* behalf at the annual general
meeting of the Company to be held on December 26, 2023 at 10:00 a.m. (Beijing time) at Room 26A1-26A5, East Tower, Hanwei
Building, No. 7 Guanghua Road, Chaoyang District, Beijing, P.R. China, and at any adjournment thereof.
*Please delete as appropriate.
NOTES
| 1. |
To be effective, this form of proxy must be duly completed, signed and delivered to Room 26A1-26A5, East Tower, Hanwei Building, No. 7 Guanghua Road, Chaoyang District, Beijing, P.R. China for the attention of director Yang Jianyu or emailed to botao.shi@ccm.cn no later than the time for holding the meeting or the adjourned meeting at which the proxy is to be used. |
| |
|
| 2. |
Any alterations made to this form of proxy should be initialled. |
| |
|
| 3. |
In the case of a corporation, this instruction should be given under its Common Seal or under the hand of an officer, attorney or other person duly authorised in writing to sign the same. |
| Date: |
|
|
| |
|
| Signed by or on behalf of the above named |
|
| |
|
| |
|
| Name: |
|
Concord Medical Services (NYSE:CCM)
Historical Stock Chart
From Oct 2024 to Nov 2024
Concord Medical Services (NYSE:CCM)
Historical Stock Chart
From Nov 2023 to Nov 2024
